Fulcrum Therapeutics Inc (FULC)
7.57
-0.02
(-0.26%)
USD |
NASDAQ |
May 09, 15:01
Fulcrum Therapeutics Total Liabilities (Quarterly): 22.50M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.50M |
| September 30, 2023 | 23.42M |
| June 30, 2023 | 24.90M |
| March 31, 2023 | 24.86M |
| December 31, 2022 | 27.74M |
| September 30, 2022 | 26.39M |
| June 30, 2022 | 34.48M |
| March 31, 2022 | 31.09M |
| December 31, 2021 | 23.46M |
| September 30, 2021 | 24.94M |
| June 30, 2021 | 26.99M |
| Date | Value |
|---|---|
| March 31, 2021 | 28.72M |
| December 31, 2020 | 34.40M |
| September 30, 2020 | 37.23M |
| June 30, 2020 | 22.73M |
| March 31, 2020 | 24.22M |
| December 31, 2019 | 23.29M |
| September 30, 2019 | 13.83M |
| June 30, 2019 | 11.70M |
| March 31, 2019 | 10.14M |
| December 31, 2018 | 9.771M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.70M
Minimum
Jun 2019
37.23M
Maximum
Sep 2020
25.63M
Average
24.90M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 128.54B |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 257.69M |
| Shareholders Equity (Quarterly) | 235.19M |
| Current Ratio | 17.71 |